CATALOGO DEI PRODOTTI DELLA RICERCA

CETTO, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.494
EU - Europa 5.014
AS - Asia 3.709
SA - Sud America 548
AF - Africa 42
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.821
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.445
SG - Singapore 1.609
GB - Regno Unito 1.559
CN - Cina 1.273
SE - Svezia 606
IT - Italia 531
BR - Brasile 474
FR - Francia 458
IE - Irlanda 445
RU - Federazione Russa 417
FI - Finlandia 408
HK - Hong Kong 371
DE - Germania 351
KR - Corea 155
UA - Ucraina 103
VN - Vietnam 59
TR - Turchia 38
BE - Belgio 36
IN - India 33
IR - Iran 31
CA - Canada 30
JP - Giappone 23
BD - Bangladesh 20
AR - Argentina 19
IL - Israele 19
NL - Olanda 16
ZA - Sudafrica 14
UZ - Uzbekistan 11
VE - Venezuela 11
IQ - Iraq 10
AT - Austria 9
CZ - Repubblica Ceca 9
MA - Marocco 9
PL - Polonia 9
CH - Svizzera 8
CL - Cile 8
MX - Messico 8
EC - Ecuador 7
LV - Lettonia 7
NP - Nepal 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CO - Colombia 6
EG - Egitto 6
ID - Indonesia 6
PY - Paraguay 6
RO - Romania 6
UY - Uruguay 6
AL - Albania 5
ES - Italia 5
LT - Lituania 5
PE - Perù 5
BO - Bolivia 4
EU - Europa 4
PT - Portogallo 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
KE - Kenya 2
ML - Mali 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PW - Palau 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
YE - Yemen 1
Totale 15.821
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.418
Southend 1.350
Chandler 801
Singapore 767
Dallas 598
Woodbridge 446
Dublin 444
Hong Kong 366
Ashburn 363
Ann Arbor 296
Houston 283
Lawrence 163
Princeton 163
Beijing 160
Wilmington 153
Nanjing 118
New York 118
Jinan 113
Shenyang 109
Los Angeles 104
Hebei 89
Buffalo 81
Milan 79
The Dalles 74
Tianjin 64
Zhengzhou 52
Helsinki 51
Ningbo 51
Boardman 49
São Paulo 45
Haikou 44
Nanchang 44
Hangzhou 41
Sindelfingen 41
Changsha 40
Munich 38
Santa Clara 36
Brussels 35
Taizhou 34
Verona 33
Jiaxing 31
Turku 29
Lancaster 27
Ho Chi Minh City 25
Norwalk 25
Redondo Beach 25
Columbus 24
Falls Church 23
Fairfield 22
Rome 22
Seattle 22
Taiyuan 21
Guangzhou 20
Moscow 20
Rio de Janeiro 20
Tokyo 19
Fuzhou 18
Chicago 17
Philadelphia 16
Brooklyn 14
Council Bluffs 13
Lanzhou 13
San Francisco 13
Belo Horizonte 12
Kent 12
Parma 12
Hanoi 11
Toronto 11
Brasília 10
Curitiba 10
Montreal 10
Tashkent 10
Boston 9
Dearborn 9
London 9
Amsterdam 8
Auburn Hills 8
Campinas 8
Napoli 8
Phoenix 8
Redwood City 8
Cambridge 7
Guarulhos 7
Istanbul 7
Johannesburg 7
Nuremberg 7
San Diego 7
Seoul 7
Zanjan 7
Bologna 6
Clearwater 6
Mexico City 6
Montevideo 6
Stockholm 6
Warsaw 6
Washington 6
Atlanta 5
Chennai 5
Düsseldorf 5
Frankfurt am Main 5
Totale 10.124
Salva come PNG Salva come JPEG
Nome #
Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico. 269
Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario. 197
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 187
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 186
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 171
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 165
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 159
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 159
Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 153
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 151
Gamma Knife radiosurgery in brain metastases from testicular tumors 151
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 148
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 146
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer 146
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 143
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 140
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 140
Current trends in hematopoietic stem cell transplantation in Europe 139
A feasibility study for an hospital-based breast cancer registry. 136
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 131
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 131
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 130
Terminal transferase expression in relapsed acute myeloid leukaemia 130
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 129
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 127
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 126
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 126
Cisplatin pharmacokinetics in elderly patients 125
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 125
Analisi di linkage in famiglie con carcinoma mammario ereditario. 124
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 124
Analisi immunoistochimica per la ricerca di micrometastasi osteo midollari nel carcinoma mammario. 122
Comportamento dell'ACE e del CEA in pazienti affetti da carcinoma polmonare. 121
[Idiopathic aneurysm of the right ventricle. Report of a case] 119
Gram-negative septicemia in patients with hematologic malignancies 119
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 119
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 119
Virtual colonoscopy in the surveillance of suspected HNPCC carriers: a preliminary study 118
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 117
Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells 116
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 115
La terapia ad alte dosi nel carcinoma mammario metastatico e nella mastite carcinomatosa. 115
Fanconi's anaemia in adults: study of three families 112
Cytofluorymetric evaluation of DNA ploidy in lung cancer: a broncoscopic study 112
Anemia, cancro e chemioterapia antiblastica. 112
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors 111
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer 109
Ricerca immunoistochimica di micrometastasi osteo midollari in 33 pazienti portatrici di carcinoma della mammella. 109
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 109
A good death for cancer patients:still a dream? 107
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 107
Evoluzione del concetto di dose in chemioterapia: basi teoriche e modelli matematici. Cetto G.L., Molino A. in: “L’intensità di dose in Oncologia Medica”. G.Bonadonna, G.Robustelli della Cuna eds., Edimes, Progressi in Oncologia Clinica 4: pag. 11-22, Pavia 1995 106
Caratterizzazione di una nuova linea cellulare di melanoma umano. 106
Use of the ratio of time to progression following first and second line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma 105
Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.). 105
Attività di un Registro Tumori di Patologia Mammaria su base ospedaliera. 105
Clinical evaluation of 51 patients with small cell lung cancer (SCLC). 104
Comparative analysis of three different methods in detecting breast cells in bone marrow. 104
Attività proliferativa del carcinoma mammario: studio su 329 pazienti. 104
The antiemetic activity of high dose metoclopramide and high dose alizapride in combination with lorazepam in patients receiving chemotherapy 103
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer 102
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study 102
Efficacy of chemotherapy in two cases of extranodal retroperitoneal germ cell tumors. 102
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 101
Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato. 101
Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis 100
Analisi puntiforme dei valori sierici del CA 15.3 e del CEA in pazienti con carcinoma della mammella. 100
A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results. 99
Correlazione tra trattamento adiuvante (chemioterapia e/o ormonoterapia), dosaggio RE e RPg, N , comparsa di metastasi in 150 pazienti con carcinoma mammario. 99
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 96
Anemia, cancro e chemioterapia antiblastica. 95
Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases. 95
Ifosfamide encephalopathy: a case report 94
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 94
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia 93
New standards in the chemotherapy of metastatic hormone-refractory prostate cancer 93
Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide vs CMF in high-risk premenopausal breast cancer patients (pts). Prospective randomized phase III trial. 92
Comportamento del CA 15 3 nelle pazienti affette da carcinoma mammario (stadio I III). 92
Dosaggio della NSE in pazienti affetti da tumori di origine neuroectodermica. 92
Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients 91
Economic aspect of high-dose-chemotherapy (HDC): a clinician’s perspective review 91
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (ec) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial. E 91
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients. 97. 91
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 91
Neo-adjuvant chemotherapy in non-smallcell lung cancer (SSCLC) 90
Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi. 90
Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.). 89
Efficacia antiemetica dell'ondansetron (GR 38032): continuità dell'attività terapeutica. 89
Comparison of two different methods of evaluating proliferative index in breast cancer. 89
Impact of a breast cancer registry on the management of breast cancer patients 88
Chemotherapy for metastatic melanoma 88
Phase I°/II° trial of recombinant alfha 2 interferon (IFN) and Vinblastine (VBL) in metastatic renal cell cancer (MRCC). 88
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 88
Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. 87
Bone marrow micrometastases in breast cancer patients. 87
Bone metastases from primary cardiac sarcoma: case report 87
Multicentric phase II trial of gemcitabine plus epirubucin plus paclitaxel as first-line chemotherapy in metastatic breast cancer. 86
Prognostic significance of estrogen and progesterone receptors (RE and PR) in 234 breast cancer patients. 86
Significato Prognostico dei recettori per estrogeni (RE) e per progesterone (RP) nel cancro mammario. 86
Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 85
Totale 11.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.701
article - articoli 24.058
book - libri 2.421
conference - conferenze 29.222
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.001 0 0 0 109 147 206 16 176 139 11 161 36
2021/20221.469 76 457 13 204 78 37 33 76 64 31 127 273
2022/20232.534 203 216 270 361 345 624 23 141 269 18 45 19
2023/20241.043 39 114 89 113 146 150 39 39 5 48 168 93
2024/20253.050 179 216 96 489 148 56 163 106 508 220 211 658
2025/20261.806 637 529 558 82 0 0 0 0 0 0 0 0
Totale 15.882